Stocks and Investing Stocks and Investing
Thu, May 27, 2021
Wed, May 26, 2021
Tue, May 25, 2021
Mon, May 24, 2021
Fri, May 21, 2021

Eliana Merle Initiated (APLS) at Strong Buy and Held Target at $82 on, May 21st, 2021


Published on 2024-10-27 16:45:43 - WOPRAI, Eliana Merle
  Print publication without navigation


Eliana Merle of UBS, Initiated "Apellis Pharmaceuticals, Inc." (APLS) at Strong Buy and Held Target at $82 on, May 21st, 2021.

Eliana has made no other calls on APLS in the last 4 months.



There are 2 other peers that have a rating on APLS. Out of the 2 peers that are also analyzing APLS, 1 agrees with Eliana's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Tiago Fauth of "Credit Suisse" Maintained at Hold with Increased Target to $39 on, Thursday, April 29th, 2021


This is the rating of the analyst that currently disagrees with Eliana


  • Madhu Kumar of "Goldman Sachs" Initiated at Strong Buy and Held Target at $130 on, Friday, April 16th, 2021